12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CYT003: Completed Phase IIb enrollment

Cytos completed enrollment of about 360 patients with moderate to severe allergic asthma not sufficiently controlled on standard controller therapy in a double-blind, placebo-controlled, international Phase IIb trial evaluating 3 dose...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >